Know Cancer

or
forgot password
  • cancer clinical trials in connecticut

  • Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Middlesex Hospital Cancer Center
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Eastern Connecticut Hematology and Oncology Associates
    Colorectal Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    Bridgeport Hospital

    Trial Locations
    Bridgeport Hospital
    St. Vincent's Medical Center
    Yale Cancer Center
    Hospital of Saint Raphael
    William W. Backus Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Prostate Cancer
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Helen and Harry Gray Cancer Center at Hartford Hospital

    Trial Locations
    Helen and Harry Gray Cancer Center at Hartford Hospital
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Yale Cancer Center
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Bridgeport Hospital

    Trial Locations
    Bridgeport Hospital
    Saint Vincent's Medical Center
    Danbury Hospital
    University of Connecticut
    Greenwich Hospital
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    Manchester Memorial Hospital
    Middlesex Hospital
    The Hospital of Central Connecticut
    Hospital of Saint Raphael
    Eastern Connecticut Hematology and Oncology Associates
    Stamford Hospital
    Harold Leever Regional Cancer Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
    Research Site
    Danbury, Connecticut
    Bone Metastases in Subjects With Advanced Breast Cancer
    Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Prostate Cancer, Neoplasm Metastasis
    Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
    Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis Hospital and Medical Center
    Hematology Oncology, P.C.
    Melanoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Greenwich Hospital

    Trial Locations
    Greenwich Hospital
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    Midstate Medical Center
    Middlesex Hospital
    The Hospital of Central Connecticut
    Yale University
    Norwalk Hospital
    Eastern Connecticut Hematology and Oncology Associates
    Stamford Hospital
    Connecticut Oncology and Hematology LLP
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    Manchester Memorial Hospital
    Yale University
    Eastern Connecticut Hematology and Oncology Associates
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    STEPP: A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-line Irinotecan Based Chemotherapy
    Research Site
    Danbury, Connecticut
    Metastatic Colorectal Cancer, Skin Rash, Skin Toxicities, Colon Cancer, Colorectal Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Kidney Cancer
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Manchester Memorial Hospital
    Manchester, Connecticut 06040-4188
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Advanced Solid Cancers
    A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    Peripheral T-Cell Lymphoma
    Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
    Yale Comprehensive Cancer Center at Yale University School of Medicine
    New Haven, Connecticut 06520-8064
    B-Cell Lymphoma
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma